Cite Filings / DNLI / 0001714899-19-000018
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
S-3ASR

Registration Statement

Denali Therapeutics Inc. · Filed 2019-03-12 · Acc 0001714899-19-000018

Documents 1

  • S-3ASR Registration Statement , forms-3asr31219.htm

Around this filing

  • 2022-02-28 S-3ASR Registration Statement
  • 2019-03-18 4 Chief Medical Officer sold 1,000 shares at $25.01 ($25,010)
  • 2019-03-13 4 COO and Secretary sold 7,500 shares at an average $22.58 ($169,313)
  • 2019-03-12 S-3ASR Registration Statement
  • 2019-03-12 S-8 Securities Offered to Employees in Benefit Plans
  • 2019-03-12 10-K Annual Report
  • 2019-03-12 8-K Results of operations

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading forms-3asr31219.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…